Hainan Huluwa Pharmaceutical Group Co Ltd Capital Reinvestment Ratio
Hainan Huluwa Pharmaceutical Group Co Ltd capital reinvestment ratio. Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Capital Reinvestment Ratio of 0.21x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥44.34 Million) in capital expenditures (CN¥9.15 Million). Check Hainan Huluwa Pharmaceutical Group Co Lt total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
Capital reinvestment ratio of Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2025. This chart tracks Hainan Huluwa Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore 605199 net assets growth trend to track the company's year-over-year net asset growth rate.
Hainan Huluwa Pharmaceutical Group Co Ltd Capital Reinvestment Ratio by Year (2016–2025)
Hainan Huluwa Pharmaceutical Group Co Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see Hainan Huluwa Pharmaceutical Group Co Lt operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.61x | CN¥136.85 Million | CN¥83.67 Million | ▼ -96.5% |
| 2023 | 17.32x | CN¥28.25 Million | CN¥489.20 Million | ▲ +953.6% |
| 2022 | 1.64x | CN¥238.71 Million | CN¥392.32 Million | ▲ +22.4% |
| 2021 | 1.34x | CN¥102.48 Million | CN¥137.62 Million | ▼ -92.5% |
| 2020 | 18.01x | CN¥3.30 Million | CN¥59.42 Million | ▲ +4355.8% |
| 2019 | 0.40x | CN¥144.51 Million | CN¥58.40 Million | ▼ -82.4% |
| 2018 | 2.29x | CN¥31.80 Million | CN¥72.82 Million | ▲ +30.7% |
| 2017 | 1.75x | CN¥89.96 Million | CN¥157.58 Million | ▲ +177.6% |
| 2016 | 0.63x | CN¥64.96 Million | CN¥40.99 Million | — |